Adverse event profiles mirrored GLP-1 agonists: nausea (38%), diarrhoea (24%), vomiting (18%), with most events resolving after the first 48 weeks
Although sufficient evidence is still lacking, the therapeutic effects of behavioural and psychological interventions and brain stimulation on autistic patients must have a theoretical basis related to neurobiochemistry and signal transduction
Now there are two levels of health optimisation: you go to a doctor for the most conservative treatment plan that is vetted and validated by legal bodies, but you use AI to navigate slightly more non-conservative or unusual plans, ie peptides
Allergy and immune resilience: exploring the gut-immune connection and supportive approaches
I should be upfront here: the human clinical trial data is thin
The peptide repairs damage, but proper loading is needed to ensure the repaired tissue develops functional strength